Alkem Laboratories Q4 Results
- BSE: 539523
- NSE: ALKEM
- ISIN: INE540L01014
- Sector: Biotechnology & Drugs
BSE
5,643.40
34.95 (0.62%)
34.95 (0.62%)Volume2.85 K
Updated: Fri 7 Aug, 2026 | 15:14:33
NSE
5,620.0022.50 (0.40%)
22.50 (0.40%)Volume76.17 K
Updated: Fri 7 Aug, 2026 | 15:50:06
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹3,603.32 Cr.(14.62%)
- Operating Profit₹276.66 Cr.(-0.77%)
- Profit After Tax₹236.46 Cr.(-22.69%)
- Operating Margin7.68%(-13.42%)
Note: Comparison is on YoY basis
Quarterly - Alkem Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 3,326.66 | 3,056.62 | 8.83% | 2,613.63 | 16.12% |
| Depreciation/ Amortization | 105.76 | 95.01 | 11.31% | 83.43 | -5.98% |
| Operating Income | 276.66 | 680.20 | -59.33% | 322.19 | -0.77% |
| Net Income | 236.46 | 636.02 | -62.82% | 293.56 | -22.69% |
| Other Operating Expenses Total | 1,125.96 | 914.60 | 23.11% | 920.61 | 31.41% |
| Net Income Before Taxes | 422.28 | 780.70 | -45.91% | 367.34 | 6.71% |
| Total Revenue | 3,603.32 | 3,736.82 | -3.57% | 2,935.82 | 14.62% |
| Selling/ General/ Admin Expenses Total | 712.10 | 721.51 | -1.30% | 505.83 | 15.54% |
| Diluted Normalized EPS | 26.49 | 56.88 | -53.43% | 24.55 | 3.56% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.